Diabetic cardiomyopathy: factual or factoid?

SUMMARY Although long ago described, there is no established consensus regarding the real existence of Diabetic Cardiomyopathy (CMPDM). Due to its complex pathophysiology, it has been difficult for clinical and experimental research to establish clear connections between diabetes mellitus (DM) and heart failure (HF), as well as to solve the mechanisms of the underlying myocardial disease. However, the epidemiological evidence of the relationship of these conditions is undisputed. The interest in understanding this disease has intensified due to the recent results of clinical trials evaluating new glucose-lowering drugs, such as sodium-glucose transporter inhibitors 2, which demonstrated favorable responses considering the prevention and treatment of HF in patients with DM. In this review we cover aspects of the epidemiology of CMPDM and its possible pathogenic mechanisms, as well as, present the main cardiac phenotypes of CMPDM (HF with preserved and reduced ejection fraction) and implications of the therapeutic management of this disease.

Saved in:
Bibliographic Details
Main Authors: Quinaglia,Thiago, Oliveira,Daniela C., Matos-Souza,José Roberto, Sposito,Andrei C.
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100061
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302019000100061
record_format ojs
spelling oai:scielo:S0104-423020190001000612019-02-05Diabetic cardiomyopathy: factual or factoid?Quinaglia,ThiagoOliveira,Daniela C.Matos-Souza,José RobertoSposito,Andrei C. Diabetes mellitus Cardiomyopathies Hypoglycemic agents Heart failure SUMMARY Although long ago described, there is no established consensus regarding the real existence of Diabetic Cardiomyopathy (CMPDM). Due to its complex pathophysiology, it has been difficult for clinical and experimental research to establish clear connections between diabetes mellitus (DM) and heart failure (HF), as well as to solve the mechanisms of the underlying myocardial disease. However, the epidemiological evidence of the relationship of these conditions is undisputed. The interest in understanding this disease has intensified due to the recent results of clinical trials evaluating new glucose-lowering drugs, such as sodium-glucose transporter inhibitors 2, which demonstrated favorable responses considering the prevention and treatment of HF in patients with DM. In this review we cover aspects of the epidemiology of CMPDM and its possible pathogenic mechanisms, as well as, present the main cardiac phenotypes of CMPDM (HF with preserved and reduced ejection fraction) and implications of the therapeutic management of this disease.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.65 n.1 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100061en10.1590/1806-9282.65.1.69
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Quinaglia,Thiago
Oliveira,Daniela C.
Matos-Souza,José Roberto
Sposito,Andrei C.
spellingShingle Quinaglia,Thiago
Oliveira,Daniela C.
Matos-Souza,José Roberto
Sposito,Andrei C.
Diabetic cardiomyopathy: factual or factoid?
author_facet Quinaglia,Thiago
Oliveira,Daniela C.
Matos-Souza,José Roberto
Sposito,Andrei C.
author_sort Quinaglia,Thiago
title Diabetic cardiomyopathy: factual or factoid?
title_short Diabetic cardiomyopathy: factual or factoid?
title_full Diabetic cardiomyopathy: factual or factoid?
title_fullStr Diabetic cardiomyopathy: factual or factoid?
title_full_unstemmed Diabetic cardiomyopathy: factual or factoid?
title_sort diabetic cardiomyopathy: factual or factoid?
description SUMMARY Although long ago described, there is no established consensus regarding the real existence of Diabetic Cardiomyopathy (CMPDM). Due to its complex pathophysiology, it has been difficult for clinical and experimental research to establish clear connections between diabetes mellitus (DM) and heart failure (HF), as well as to solve the mechanisms of the underlying myocardial disease. However, the epidemiological evidence of the relationship of these conditions is undisputed. The interest in understanding this disease has intensified due to the recent results of clinical trials evaluating new glucose-lowering drugs, such as sodium-glucose transporter inhibitors 2, which demonstrated favorable responses considering the prevention and treatment of HF in patients with DM. In this review we cover aspects of the epidemiology of CMPDM and its possible pathogenic mechanisms, as well as, present the main cardiac phenotypes of CMPDM (HF with preserved and reduced ejection fraction) and implications of the therapeutic management of this disease.
publisher Associação Médica Brasileira
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100061
work_keys_str_mv AT quinagliathiago diabeticcardiomyopathyfactualorfactoid
AT oliveiradanielac diabeticcardiomyopathyfactualorfactoid
AT matossouzajoseroberto diabeticcardiomyopathyfactualorfactoid
AT spositoandreic diabeticcardiomyopathyfactualorfactoid
_version_ 1756410011910668288